BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 28113240)

  • 1. Modeling Day-to-Day Variability of Glucose-Insulin Regulation Over 12-Week Home Use of Closed-Loop Insulin Delivery.
    Yue Ruan ; Wilinska ME; Thabit H; Hovorka R
    IEEE Trans Biomed Eng; 2017 Jun; 64(6):1412-1419. PubMed ID: 28113240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of intraday metabolic profiles during closed-loop glucose control in individuals with type 1 diabetes.
    Kanderian SS; Weinzimer S; Voskanyan G; Steil GM
    J Diabetes Sci Technol; 2009 Sep; 3(5):1047-57. PubMed ID: 20144418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Run-to-run tuning of model predictive control for type 1 diabetes subjects: in silico trial.
    Magni L; Forgione M; Toffanin C; Dalla Man C; Kovatchev B; De Nicolao G; Cobelli C
    J Diabetes Sci Technol; 2009 Sep; 3(5):1091-8. PubMed ID: 20144422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of insulin lispro in type 2 diabetes during closed-loop insulin delivery.
    Ruan Y; Thabit H; Kumareswaran K; Hovorka R
    Comput Methods Programs Biomed; 2014 Nov; 117(2):298-307. PubMed ID: 25092225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Model-based blood glucose control for Type 1 diabetes via parametric programming.
    Dua P; Doyle FJ; Pistikopoulos EN
    IEEE Trans Biomed Eng; 2006 Aug; 53(8):1478-91. PubMed ID: 16916082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modelling endogenous insulin concentration in type 2 diabetes during closed-loop insulin delivery.
    Ruan Y; Thabit H; Wilinska ME; Hovorka R
    Biomed Eng Online; 2015 Mar; 14():19. PubMed ID: 25889091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Variable State Dimension Approach to Meal Detection and Meal Size Estimation: In Silico Evaluation Through Basal-Bolus Insulin Therapy for Type 1 Diabetes.
    Xie J; Wang Q
    IEEE Trans Biomed Eng; 2017 Jun; 64(6):1249-1260. PubMed ID: 28541188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A semiclosed-loop optimal control system for blood glucose level in diabetics.
    Ibbini MS; Masadeh MA; Amer MM
    J Med Eng Technol; 2004; 28(5):189-96. PubMed ID: 15370997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of insulin feedback on closed loop glucose control.
    Steil GM; Palerm CC; Kurtz N; Voskanyan G; Roy A; Paz S; Kandeel FR
    J Clin Endocrinol Metab; 2011 May; 96(5):1402-8. PubMed ID: 21367930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluctuations of Hyperglycemia and Insulin Sensitivity Are Linked to Menstrual Cycle Phases in Women With T1D.
    Brown SA; Jiang B; McElwee-Malloy M; Wakeman C; Breton MD
    J Diabetes Sci Technol; 2015 Oct; 9(6):1192-9. PubMed ID: 26468135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An improved PID switching control strategy for type 1 diabetes.
    Marchetti G; Barolo M; Jovanovic L; Zisser H; Seborg DE
    IEEE Trans Biomed Eng; 2008 Mar; 55(3):857-65. PubMed ID: 18334377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fuzzy-based controller for glucose regulation in type-1 diabetic patients by subcutaneous route.
    Campos-Delgado DU; Hernández-Ordoñez M; Femat R; Gordillo-Moscoso A
    IEEE Trans Biomed Eng; 2006 Nov; 53(11):2201-10. PubMed ID: 17073325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-Time Model-Based Fault Detection of Continuous Glucose Sensor Measurements.
    Turksoy K; Roy A; Cinar A
    IEEE Trans Biomed Eng; 2017 Jul; 64(7):1437-1445. PubMed ID: 26930674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling, identification and nonlinear model predictive control of type I diabetic patient.
    Schlotthauer G; Gamero LG; Torres ME; Nicolini GA
    Med Eng Phys; 2006 Apr; 28(3):240-50. PubMed ID: 15964233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One-Day Bayesian Cloning of Type 1 Diabetes Subjects: Toward a Single-Day UVA/Padova Type 1 Diabetes Simulator.
    Visentin R; Man CD; Cobelli C
    IEEE Trans Biomed Eng; 2016 Nov; 63(11):2416-2424. PubMed ID: 26930671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Automated overnight closed-loop glucose control in young children with type 1 diabetes.
    Elleri D; Allen JM; Nodale M; Wilinska ME; Mangat JS; Larsen AM; Acerini CL; Dunger DB; Hovorka R
    Diabetes Technol Ther; 2011 Apr; 13(4):419-24. PubMed ID: 21355719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variability of Insulin Requirements Over 12 Weeks of Closed-Loop Insulin Delivery in Adults With Type 1 Diabetes.
    Ruan Y; Thabit H; Leelarathna L; Hartnell S; Willinska ME; Dellweg S; Benesch C; Mader JK; Holzer M; Kojzar H; Evans ML; Pieber TR; Arnolds S; Hovorka R;
    Diabetes Care; 2016 May; 39(5):830-2. PubMed ID: 26965717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting subcutaneous glucose concentration using a latent-variable-based statistical method for type 1 diabetes mellitus.
    Zhao C; Dassau E; Jovanovič L; Zisser HC; Doyle FJ; Seborg DE
    J Diabetes Sci Technol; 2012 May; 6(3):617-33. PubMed ID: 22768893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-prandial plasma glucose prediction in type I diabetes based on Impulse Response Models.
    Stahl F; Johansson R; Renard E
    Annu Int Conf IEEE Eng Med Biol Soc; 2010; 2010():1324-7. PubMed ID: 21095929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Closed loop insulin delivery in diabetes.
    Battelino T; Omladič JŠ; Phillip M
    Best Pract Res Clin Endocrinol Metab; 2015 Jun; 29(3):315-25. PubMed ID: 26051293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.